ResearcherFirst Affiliated Hospital of Chengdu Medical CollegeNo recent work listed

Tao Ren

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6641-4589; OpenAlex author ID A5040929986. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 5

Papers, trials and grants by year

2021: 2 papers

Papers 2

Prognostic Value of BTNL9 Combined with Genes of Proteasome and Ubiquitin System in Pancreatic Cancer Last author DOI 10.21203/rs.3.rs-955285/v1 ↗
GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma. Last author DOI 10.7717/peerj.11423 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ke Xu · 1 shared paper, 2021 · strength 0.16
- Paper Prognostic Value of BTNL9 Combined with Genes of Proteasome and Ubiquitin System in Pancreatic Cancer DOI 10.21203/rs.3.rs-955285/v1 ↗
Wei Zhou · 1 shared paper, 2021 · strength 0.14
- Paper GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma. DOI 10.7717/peerj.11423 ↗
Ke Xu · 1 shared paper, 2021 · strength 0.14
- Paper GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma. DOI 10.7717/peerj.11423 ↗
Chengyou Du · 1 shared paper, 2021 · strength 0.14
- Paper GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma. DOI 10.7717/peerj.11423 ↗
Bo Liu · 1 shared paper, 2021 · strength 0.14
- Paper GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma. DOI 10.7717/peerj.11423 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.